White Papers

  1. Minimal Residual Disease: Finding The Right Test For The New Definition Of Remission

    Measurement of Residual Disease for improved oncology trial outcomes - what factors make an MRD test most effective plus explore the pros and cons of various MRD measurement approaches.

  2. Planning And Implementing Biomarker Testing For immuno-Oncology Trials

    Exploring the challenges with the diverse clinical biomarker requirements.

  3. Clinical Road Map To Success For Over-encapsulation

    Over-encapsulation is a widely accepted blinding mechanism used throughout the clinical supplies industry, and while the process itself may appear relatively straightforward, packaging for clinical supplies is a complex process that is strictly controlled by Good Manufacturing Practices (GMP).

  4. Thriving In Value-Based Healthcare: A Guide For Cardiovascular Device Manufacturers

    Understand the challenges value-based care will present, along with success strategies for transforming them into opportunities for innovation and increased market share.

  5. How Institutions Gain Research Trial Opportunities

    How and why leading institutions have made the decision to switch from reliance on just one external IRB to partnering with multiple independent IRBs.

  6. Ten Tips For Writing Compliant Clinical Trial Participant Materials

    How to ensure participant materials are the most effective, useful, and compliant they can be.

  7. The Complete EDC Buyer’s Guide: What Should You Be Looking For?

    Navigate the process of EDC vendor selection and make a better-informed purchase decision on this key technology for clinical research.

  8. Setting The Scene In Immuno-oncology

    Applying lessons learned to the future of Immuno-oncology.

  9. A Better Way To Pay Clinical Research Sites: Automating Site Grant Payments

    How automating site grant payments can optimize payment processes for sites leading to greater site satisfaction and allowing sites to operate at peak performance and reduce errors.

  10. Understanding The Continuum Of Clinical Collaboration

    Vendor-selection processes are tilting toward finding as broad and deep a fit as possible, the better to capture the efficiencies from scale and repeatability that those moves are intended to deliver.